253663 Current status of the Department of Justice Remedies in the RICO Case Against Big Tobacco

Tuesday, November 1, 2011: 11:30 AM

Matthew Myers, JD , Campaign for Tobacco-Free Kids, Washington, DC
While the spotlight is no longer on the United States' Government's lawsuit against the major tobacco manufacturers after the decision of the United States Supreme Court, the case is not over and important issues remain to be resolved. The case is now back in Judge Gladys Kessler's trial court. The tobacco companies have argued that the enactment of the Family Smoking Prevention and Tobacco Control Act makes her remedial order moot and eliminates her jurisdiction over the case. The tobacco industry has also objected to Judge Kessler's requirement that that be required to publish “Corrective Statements” and argued that even if they are required to publish “Corrective Statements”, they should not be required to publish the statements the government has proposed or to post signs in retail outlets. They have also challenged Judge Kessler's order that they continue to maintain and put new documents into the Minnesota document depository and several other provisions of Judge Kessler's order. The Department of Justice and the Public Health Intervenors have opposed the Industry's efforts.

Learning Areas:
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related public policy

Learning Objectives:
Explain the differences between FDA regulations and the legal remedies sought in the government’s RICO suit. Discuss the implications of the legal case against tobacco companies and the implications of remedies sought by the government and the public health interveners.

Keywords: Tobacco Litigation, Tobacco Industry

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified because I have been directly involved in the litigation since the trial stage and the Campaign coordinates the participation of the public health intervenors.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.